Evommune, Inc. (EVMN) — Financial Flexibility Index
Evommune, Inc. (EVMN) has a Financial Flexibility Index of -0.86x as of December 2025. Free cash flow of $-16.59 Million (operating CF $-16.70 Million minus capex $104.00K) represents -1% of total liabilities ($19.38 Million). Also explore Evommune, Inc. net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Evommune, Inc. Financial Flexibility Index (2023–2025)
Historical Financial Flexibility Index trend for Evommune, Inc. across 3 annual periods. Check EVMN PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Evommune, Inc. (2023–2025)
Year-by-year free cash flow to debt coverage for Evommune, Inc.. For the full company profile including market capitalisation, see how much is Evommune, Inc. worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.93x | $-76.21 Million | $-76.44 Million | $19.38 Million | ▼ -1390.8% |
| 2024 | -0.26x | $-58.11 Million | $-58.20 Million | $220.29 Million | ▼ -41.3% |
| 2023 | -0.19x | $-29.85 Million | $-29.97 Million | $159.96 Million | — |